EDNRB and melanoma: Our results demonstrate that RB49, as well as xiRB49 and xiRB49-MMAE, preferentially binds to the ligand-activated ETB conformation and that the latter is particularly overrepresented in tumors with an activated ET axis such as melanoma and underrepresented in normal tissues, limiting the off-targeting of xiRB49-MMAE.